ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.97122
0.16%
Brent Oil
83.965
0.51%
Bitcoin
57,687.12
-0.95%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cabaletta Bio Inc (CABA)

  7. Cabaletta Bio Inc (CABA) Noticias

CABA Cabaletta Bio Inc

12.41
0.00 (0.00%)
Pre Mercado
Última actualización: 04:35:44
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cabaletta Bio Inc CABA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 12.41 04:35:44
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
12.41
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
21/3/202406:00GLOBECabaletta Bio Reports Fourth Quarter and Full Year 2023..
20/3/202406:00GLOBECabaletta Bio Announces FDA Granted Orphan Drug Designation..
04/3/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202407:00GLOBECabaletta Bio to Participate in Upcoming Investor..
14/2/202408:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202417:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202415:36EDGAR2Form 8-K - Current report
01/2/202415:30GLOBECabaletta Bio Announces FDA Granted Orphan Drug Designation..
31/1/202407:00GLOBECabaletta Bio to Participate in the Guggenheim Healthcare..
19/1/202417:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202406:11EDGAR2Form 8-K - Current report
08/1/202406:00GLOBECabaletta Bio Receives Additional FDA Fast Track..
02/1/202407:00GLOBECabaletta Bio to Present at the 42nd Annual J.P. Morgan..
19/12/202319:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202305:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
28/11/202315:30GLOBECabaletta Bio to Participate in the 6th Annual Evercore ISI..
28/11/202313:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
21/11/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202315:16EDGAR2Form 144 - Report of proposed sale of securities
09/11/202306:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:12EDGAR2Form 8-K - Current report
09/11/202306:00GLOBECabaletta Bio Reports Third Quarter 2023 Financial Results..
06/11/202307:15BWCellares and Cabaletta Bio Partner to Evaluate Automated..
06/11/202306:55DJNCabaletta Bio Gets FDA OK to Study CABA-201 in Generalized..
06/11/202306:03EDGAR2Form 8-K - Current report
06/11/202306:00GLOBECabaletta Bio Receives FDA Clearance of CABA-201 IND..
30/10/202307:00GLOBECabaletta Bio to Participate in Multiple Upcoming Investor..
19/10/202318:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202315:03EDGAR2Form 144 - Report of proposed sale of securities
02/10/202306:38EDGAR2Form 8-K - Current report
02/10/202306:00GLOBECabaletta Bio Receives FDA Clearance of IND Application for..
20/9/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202315:23EDGAR2Form 144 - Report of proposed sale of securities
19/9/202307:00GLOBECabaletta Bio to Participate in Upcoming Investor..
05/9/202307:45EDGAR2Form 8-K - Current report
30/8/202307:00GLOBECabaletta Bio to Participate in Multiple Upcoming Investor..
22/8/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202307:03EDGAR2Form 8-K - Current report
22/8/202307:00GLOBECabaletta Bio and WuXi Advanced Therapies Announce Expansion..
21/8/202315:19EDGAR2Form 144 - Report of proposed sale of securities
10/8/202306:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/8/202306:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:16EDGAR2Form 8-K - Current report
10/8/202306:00GLOBECabaletta Bio Reports Second Quarter 2023 Financial Results..
24/7/202307:06EDGAR2Form 8-K - Current report
24/7/202307:00GLOBECabaletta Bio Appoints Global Commercial Leader Shawn..

Su Consulta Reciente

NASDAQ
CABA
Cabaletta Bio
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados